Sugammadex, a promising reversal drug. A review of clinical trials. (Record no. 20937210)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01403 a2200397 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516042916.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201204s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1876-1038 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.2174/157488711796575559 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Makri, Ira |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120404 |
245 00 - TITLE STATEMENT | |
Title | Sugammadex, a promising reversal drug. A review of clinical trials. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Reviews on recent clinical trials |
Date of publication, distribution, etc. | Sep 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 250-5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuromuscular Blockade |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuromuscular Nondepolarizing Agents |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sugammadex |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | gamma-Cyclodextrins |
General subdivision | pharmacology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Papadima, Artemisia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lafioniati, Aimilia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pappas, Apostolos B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | George, Karanikas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nikolaos, Koronakis E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ioannis, Chrysikos D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Charalambos, Seretis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Emmanuel, Lagoudianakis E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xanthos, Theodoros |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Papadimitriou, Lila |
773 0# - HOST ITEM ENTRY | |
Title | Reviews on recent clinical trials |
Related parts | vol. 6 |
-- | no. 3 |
-- | p. 250-5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.2174/157488711796575559">https://doi.org/10.2174/157488711796575559</a> |
Public note | Available from publisher's website |
No items available.